PIRS - Pieris Pharmaceuticals EPS beats by $0.08 beats on revenue May, 11 2020 07:03 AM Pieris Pharmaceuticals Inc. Pieris Pharmaceuticals (NASDAQ:PIRS): Q1 GAAP EPS of -$0.07 beats by $0.08.More news on: Pieris Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...